Chronic Kidney Disease Trial, Recruiting NCT04819217 Sponsor: National Taiwan University Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT04819217
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 20 years of age or older at the time of screening.
  • People who have chronic kidney disease with kidney function and protein-in-urine levels within a specific range, and whose kidney function has been stable for at least 30 days before joining the trial.

Who may not be able to join:

  • People whose kidney function has dropped below a certain low level, as measured by a specific calculation called the MDRD equation.
  • People who are severely malnourished, shown by a very low level of a protein called albumin in their blood.
  • People who have severe anaemia or active bleeding in their digestive tract, with very low haemoglobin (the substance in blood that carries oxygen).
  • People who have a peptic ulcer, swollen veins in the oesophagus (the tube connecting the mouth to the stomach), a blocked bowel, or who are not able to eat or drink.
  • People who have previously had surgery on any part of their digestive system.
  • People who have chronic constipation, meaning they regularly have fewer than 3 bowel movements per week, experience straining, hard stools, a feeling of incomplete emptying, or are unable to pass stool — unless regular use of laxatives taken by mouth is able to produce bowel movements, in which case this condition alone would not prevent joining.
  • People who have had a major bleeding episode requiring a blood transfusion during their current hospital admission.
  • People who have been diagnosed — either by biopsy or by a doctor's clinical assessment — with advanced liver scarring (cirrhosis) classified as Child-Pugh grade B or C.
  • People who have received a transplant of a solid organ (such as a kidney or liver) or blood-forming cells.
  • People whose kidneys are producing very little urine, defined as less than 500 mL per day.
  • People with evidence of a blockage causing kidney injury, or with polycystic kidney disease (a genetic condition causing cysts on the kidneys).
  • People who have taken antibiotics or probiotics in the two weeks before joining the trial, or who would need to take them during the follow-up period.
  • People who have been diagnosed with cancer at any point in the five years before screening.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chau chung Wu, Ph.D., National Taiwan University Hospital

Phone: 02-23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2020
Est. completion
1 December 2030

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

The % change of UACR; The % change of Creatinine; The % change of eGFR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov